- Company Details
DESCRIPTION (provided by applicant): The World Health Organization estimates that over 350 million people are at risk of developing leishmaniasis and infection prevalence is 14 million people in the w ...SBIRPhase I2011Department of Health and Human Services
DESCRIPTION (provided by applicant): Over 250,000 new cases of head and neck cancers (HNCs) and non-small cell lung cancers (NSCLCs) are diagnosed every year in the United States. At the time of diagn ...SBIRPhase I2011Department of Health and Human Services
DESCRIPTION (provided by applicant): Vindico NanoBioTechnology Inc. (Vindico) is developing a hemoglobin-based cellular oxygen therapeutic (blood substitute), NanoHeme, based on its proprietary na ...SBIRPhase IDepartment of Health and Human Services
VINDICO NANOBIOTECHNOLOGY, INC.
LEXINGTON, KY, 40506-0286
|# of Employees:||3|
|Socially and Economically Disadvantaged:||N|